Prostate cancer is one of the most common cancers among men in Canada, and early detection can save lives. Nicole Stillger from Global News talked with Nanostics COO Catalina Vasquez about how ClarityDX Prostate works and how support from Alberta Innovates helps advance our research.
Nanostics has developed a game-changing, innovative algorithm called the ClarityDX Prostate test that helps confirm if a biopsy is needed for men with elevated PSA levels. Eighty-five percent of men with elevated PSA who have a prostate biopsy done are found to be negative for prostate cancer, so they did not need to have a biopsy.
The ClarityDX Prostate blood test is available in Alberta, BC, Saskatchewan, Ontario, and Quebec in a month it will expand to US. Vasquez says not only will the test save patients from an invasive biopsy – it will also take pressure off the healthcare system.
